Nemaura Medical Inc
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factor… Read more
Nemaura Medical Inc (NMRD) - Total Assets
Latest total assets as of December 2023: $5.17 Million USD
Based on the latest financial reports, Nemaura Medical Inc (NMRD) holds total assets worth $5.17 Million USD as of December 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Nemaura Medical Inc - Total Assets Trend (2013–2023)
This chart illustrates how Nemaura Medical Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Nemaura Medical Inc - Asset Composition Analysis
Current Asset Composition (March 2023)
Nemaura Medical Inc's total assets of $5.17 Million consist of 93.0% current assets and 7.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 69.4% |
| Accounts Receivable | $409.65K | 2.8% |
| Inventory | $1.75 Million | 12.1% |
| Property, Plant & Equipment | $641.91K | 4.4% |
| Intangible Assets | $384.09K | 2.6% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2013–2023)
This chart illustrates how Nemaura Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nemaura Medical Inc's current assets represent 93.0% of total assets in 2023, an increase from 77.7% in 2013.
- Cash Position: Cash and equivalents constituted 69.4% of total assets in 2023, down from 77.7% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 22.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 12.1% of total assets.
Nemaura Medical Inc Competitors by Total Assets
Key competitors of Nemaura Medical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Nemaura Medical Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Nemaura Medical Inc generates 0.01x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Nemaura Medical Inc is currently not profitable relative to its asset base.
Nemaura Medical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.19 | 0.83 | 3.48 |
| Quick Ratio | 0.03 | 0.65 | 3.45 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-18.62 Million | $ -2.28 Million | $ 3.22 Million |
Nemaura Medical Inc - Advanced Valuation Insights
This section examines the relationship between Nemaura Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 122.56 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -34.1% |
| Total Assets | $14.56 Million |
| Market Capitalization | $2.49K USD |
Valuation Analysis
Below Book Valuation: The market values Nemaura Medical Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Nemaura Medical Inc's assets decreased by 34.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Nemaura Medical Inc (2013–2023)
The table below shows the annual total assets of Nemaura Medical Inc from 2013 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-03-31 | $14.56 Million | -34.11% |
| 2022-03-31 | $22.10 Million | -37.29% |
| 2021-03-31 | $35.24 Million | +2788.71% |
| 2020-03-31 | $1.22 Million | -74.39% |
| 2019-03-31 | $4.76 Million | -23.85% |
| 2018-03-31 | $6.26 Million | -15.49% |
| 2017-03-31 | $7.40 Million | -23.95% |
| 2016-03-31 | $9.73 Million | +965.90% |
| 2015-03-31 | $913.11K | -55.45% |
| 2014-03-31 | $2.05 Million | +694.09% |
| 2013-03-31 | $258.13K | -- |